• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小分子 G 蛋白 Rac1 和 Ras 调节丝氨酸/苏氨酸蛋白磷酸酶 5(PP5)·细胞外信号调节激酶(ERK)复合物,参与 Raf1 的反馈调节。

Small G proteins Rac1 and Ras regulate serine/threonine protein phosphatase 5 (PP5)·extracellular signal-regulated kinase (ERK) complexes involved in the feedback regulation of Raf1.

机构信息

From the Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee 37232-6600.

出版信息

J Biol Chem. 2014 Feb 14;289(7):4219-32. doi: 10.1074/jbc.M113.518514. Epub 2013 Dec 26.

DOI:10.1074/jbc.M113.518514
PMID:24371145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3924286/
Abstract

Serine/threonine protein phosphatase 5 (PP5, PPP5C) is known to interact with the chaperonin heat shock protein 90 (HSP90) and is involved in the regulation of multiple cellular signaling cascades that control diverse cellular processes, such as cell growth, differentiation, proliferation, motility, and apoptosis. Here, we identify PP5 in stable complexes with extracellular signal-regulated kinases (ERKs). Studies using mutant proteins reveal that the formation of PP5·ERK1 and PP5·ERK2 complexes partially depends on HSP90 binding to PP5 but does not require PP5 or ERK1/2 activity. However, PP5 and ERK activity regulates the phosphorylation state of Raf1 kinase, an upstream activator of ERK signaling. Whereas expression of constitutively active Rac1 promotes the assembly of PP5·ERK1/2 complexes, acute activation of ERK1/2 fails to influence the phosphatase-kinase interaction. Introduction of oncogenic HRas (HRas(V12)) has no effect on PP5-ERK1 binding but selectively decreases the interaction of PP5 with ERK2, in a manner that is independent of PP5 and MAPK/ERK kinase (MEK) activity, yet paradoxically requires ERK2 activity. Additional studies conducted with oncogenic variants of KRas4B reveal that KRas(L61), but not KRas(V12), also decreases the PP5-ERK2 interaction. The expression of wild type HRas or KRas proteins fails to reduce PP5-ERK2 binding, indicating that the effect is specific to HRas(V12) and KRas(L61) gain-of-function mutations. These findings reveal a novel, differential responsiveness of PP5-ERK1 and PP5-ERK2 interactions to select oncogenic Ras variants and also support a role for PP5·ERK complexes in regulating the feedback phosphorylation of PP5-associated Raf1.

摘要

丝氨酸/苏氨酸蛋白磷酸酶 5(PP5,PPP5C)已知与伴侣蛋白热休克蛋白 90(HSP90)相互作用,并参与调节多个细胞信号级联反应,这些级联反应控制着多种细胞过程,如细胞生长、分化、增殖、运动和凋亡。在这里,我们鉴定出与细胞外信号调节激酶(ERK)稳定结合的 PP5。使用突变蛋白的研究表明,PP5·ERK1 和 PP5·ERK2 复合物的形成部分依赖于 HSP90 与 PP5 的结合,但不依赖于 PP5 或 ERK1/2 的活性。然而,PP5 和 ERK 活性调节 Raf1 激酶的磷酸化状态,Raf1 激酶是 ERK 信号的上游激活剂。虽然组成性激活的 Rac1 促进 PP5·ERK1/2 复合物的组装,但 ERK1/2 的急性激活不能影响磷酸酶-激酶相互作用。致癌 HRas(HRas(V12)) 的表达对 PP5-ERK1 结合没有影响,但选择性地降低 PP5 与 ERK2 的相互作用,这种方式独立于 PP5 和 MAPK/ERK 激酶(MEK)活性,但矛盾的是需要 ERK2 活性。对致癌 KRas4B 变体进行的进一步研究表明,KRas(L61),而不是 KRas(V12),也降低了 PP5-ERK2 的相互作用。野生型 HRas 或 KRas 蛋白的表达不能降低 PP5-ERK2 的结合,表明这种效应是 HRas(V12)和 KRas(L61)功能获得性突变所特有的。这些发现揭示了 PP5-ERK1 和 PP5-ERK2 相互作用对选择致癌 Ras 变体的新型、差异反应性,并支持 PP5·ERK 复合物在调节与 PP5 相关的 Raf1 的反馈磷酸化中的作用。

相似文献

1
Small G proteins Rac1 and Ras regulate serine/threonine protein phosphatase 5 (PP5)·extracellular signal-regulated kinase (ERK) complexes involved in the feedback regulation of Raf1.小分子 G 蛋白 Rac1 和 Ras 调节丝氨酸/苏氨酸蛋白磷酸酶 5(PP5)·细胞外信号调节激酶(ERK)复合物,参与 Raf1 的反馈调节。
J Biol Chem. 2014 Feb 14;289(7):4219-32. doi: 10.1074/jbc.M113.518514. Epub 2013 Dec 26.
2
RAF1/BRAF dimerization integrates the signal from RAS to ERK and ROKα.RAF1/BRAF二聚化整合了从RAS到ERK和ROKα的信号。
Sci Signal. 2017 Mar 7;10(469):eaai8482. doi: 10.1126/scisignal.aai8482.
3
Cell type-specific importance of ras-c-raf complex association rate constants for MAPK signaling.Ras-c-Raf复合物缔合速率常数对MAPK信号传导的细胞类型特异性重要性。
Sci Signal. 2009 Jul 28;2(81):ra38. doi: 10.1126/scisignal.2000397.
4
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.RAF 抑制剂使野生型 RAF 激活 MAPK 通路并增强其生长。
Nature. 2010 Mar 18;464(7287):431-5. doi: 10.1038/nature08833. Epub 2010 Feb 3.
5
mTORC1 upregulation via ERK-dependent gene expression change confers intrinsic resistance to MEK inhibitors in oncogenic KRas-mutant cancer cells.通过依赖ERK的基因表达变化上调mTORC1赋予致癌性KRas突变癌细胞对MEK抑制剂的内在抗性。
Oncogene. 2015 Nov 5;34(45):5607-16. doi: 10.1038/onc.2015.16. Epub 2015 Feb 23.
6
Rac-PAK signaling stimulates extracellular signal-regulated kinase (ERK) activation by regulating formation of MEK1-ERK complexes.Rac-PAK信号传导通过调节MEK1-ERK复合物的形成来刺激细胞外信号调节激酶(ERK)的激活。
Mol Cell Biol. 2002 Sep;22(17):6023-33. doi: 10.1128/MCB.22.17.6023-6033.2002.
7
Regulation of the Raf-MEK-ERK pathway by protein phosphatase 5.蛋白磷酸酶5对Raf-MEK-ERK信号通路的调控
Nat Cell Biol. 2006 Sep;8(9):1011-6. doi: 10.1038/ncb1465. Epub 2006 Aug 6.
8
Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.ERK2而非ERK1的缺失消除了致癌性Ras诱导的衰老。
Cell Signal. 2013 Dec;25(12):2540-7. doi: 10.1016/j.cellsig.2013.08.014. Epub 2013 Aug 30.
9
Ras effector mutant expression suggest a negative regulator inhibits lung tumor formation.Ras效应器突变体表达提示一种负调节因子抑制肺肿瘤形成。
PLoS One. 2014 Jan 28;9(1):e84745. doi: 10.1371/journal.pone.0084745. eCollection 2014.
10
Activation of the RAS/RAF/ERK signaling pathway contributes to resistance to sunitinib in thyroid carcinoma cell lines.RAS/RAF/ERK 信号通路的激活导致甲状腺癌细胞系对舒尼替尼产生耐药性。
J Clin Endocrinol Metab. 2012 Jun;97(6):E898-906. doi: 10.1210/jc.2011-3269. Epub 2012 Mar 22.

引用本文的文献

1
SUMOylation of protein phosphatase 5 regulates phosphatase activity and substrate release.蛋白质磷酸酶 5 的 SUMOylation 调节磷酸酶活性和底物释放。
EMBO Rep. 2024 Nov;25(11):4636-4654. doi: 10.1038/s44319-024-00250-2. Epub 2024 Sep 20.
2
Targeting CRAF kinase in anti-cancer therapy: progress and opportunities.靶向 CRAF 激酶的抗癌治疗:进展与机遇。
Mol Cancer. 2023 Dec 18;22(1):208. doi: 10.1186/s12943-023-01903-x.
3
Systematic Interrogation of the Temperature Perturbation in the Insulin Signaling Pathway for Optogenetic Stimulation.系统探究光遗传学刺激胰岛素信号通路中的温度扰动。
Cells. 2022 Oct 5;11(19):3136. doi: 10.3390/cells11193136.
4
MicroRNA-365b-3p represses the proliferation and promotes the apoptosis of non-small cell lung cancer cells by targeting PPP5C.微小RNA-365b-3p通过靶向PPP5C抑制非小细胞肺癌细胞的增殖并促进其凋亡。
Oncol Lett. 2021 May;21(5):389. doi: 10.3892/ol.2021.12650. Epub 2021 Mar 17.
5
TNFAIP8 promotes AML chemoresistance by activating ERK signaling pathway through interaction with Rac1.TNFAIP8 通过与 Rac1 相互作用激活 ERK 信号通路促进 AML 耐药性。
J Exp Clin Cancer Res. 2020 Aug 14;39(1):158. doi: 10.1186/s13046-020-01658-z.
6
Structure and function of the co-chaperone protein phosphatase 5 in cancer.抑癌蛋白磷酸酶 5 共伴侣的结构与功能。
Cell Stress Chaperones. 2020 May;25(3):383-394. doi: 10.1007/s12192-020-01091-3. Epub 2020 Apr 2.
7
The Antitumor Drug LB-100 Is a Catalytic Inhibitor of Protein Phosphatase 2A (PPP2CA) and 5 (PPP5C) Coordinating with the Active-Site Catalytic Metals in PPP5C.抗肿瘤药物 LB-100 是蛋白磷酸酶 2A(PPP2CA)和 5(PPP5C)的催化抑制剂,与 PPP5C 的活性位点催化金属配位。
Mol Cancer Ther. 2019 Mar;18(3):556-566. doi: 10.1158/1535-7163.MCT-17-1143. Epub 2019 Jan 24.
8
Leishmania phosphatase PP5 is a regulator of HSP83 phosphorylation and essential for parasite pathogenicity.利什曼原虫磷酸酶PP5是HSP83磷酸化的调节因子,对寄生虫致病性至关重要。
Parasitol Res. 2018 Sep;117(9):2971-2985. doi: 10.1007/s00436-018-5994-4. Epub 2018 Jul 8.
9
Four and a half LIM domain protein signaling and cardiomyopathy.四半LIM结构域蛋白信号传导与心肌病
Biophys Rev. 2018 Aug;10(4):1073-1085. doi: 10.1007/s12551-018-0434-3. Epub 2018 Jun 20.
10
Protein phosphatase 5 regulates titin phosphorylation and function at a sarcomere-associated mechanosensor complex in cardiomyocytes.蛋白磷酸酶 5 调节肌节相关机械感受器复合物中肌联蛋白的磷酸化和功能。
Nat Commun. 2018 Jan 17;9(1):262. doi: 10.1038/s41467-017-02483-3.

本文引用的文献

1
RNAi screens in mice identify physiological regulators of oncogenic growth.RNAi 筛选在小鼠中鉴定出致癌生长的生理调节剂。
Nature. 2013 Sep 12;501(7466):185-90. doi: 10.1038/nature12464. Epub 2013 Aug 14.
2
ERK2 but not ERK1 mediates HGF-induced motility in non-small cell lung carcinoma cell lines.ERK2 而非 ERK1 介导了非小细胞肺癌细胞系中 HGF 诱导的迁移。
J Cell Sci. 2013 Jun 1;126(Pt 11):2381-91. doi: 10.1242/jcs.115832. Epub 2013 Apr 2.
3
Endothelial ERK signaling controls lymphatic fate specification.内皮细胞 ERK 信号控制淋巴管命运的指定。
J Clin Invest. 2013 Mar;123(3):1202-15. doi: 10.1172/JCI63034. Epub 2013 Feb 8.
4
The case for intrinsically disordered proteins playing contributory roles in molecular recognition without a stable 3D structure.内在无序蛋白质在没有稳定三维结构的情况下在分子识别中发挥作用的情况。
F1000 Biol Rep. 2013;5:1. doi: 10.3410/B5-1. Epub 2013 Jan 11.
5
Specificity of linear motifs that bind to a common mitogen-activated protein kinase docking groove.线性基序特异性结合到一个共同的有丝分裂原激活的蛋白激酶对接槽。
Sci Signal. 2012 Oct 9;5(245):ra74. doi: 10.1126/scisignal.2003004.
6
Extracellular signal-regulated kinase 2 (ERK2) mediates phosphorylation and inactivation of nuclear interaction partner of anaplastic lymphoma kinase (NIPA) at G2/M.细胞外信号调节激酶 2(ERK2)在 G2/M 期介导间变性淋巴瘤激酶(ALK)核相互作用伴侣 NIPA 的磷酸化和失活。
J Biol Chem. 2012 Nov 2;287(45):37997-8005. doi: 10.1074/jbc.M112.373464. Epub 2012 Sep 6.
7
Bell-shaped and ultrasensitive dose-response in phosphorylation-dephosphorylation cycles: the role of kinase-phosphatase complex formation.磷酸化-去磷酸化循环中的钟形超敏剂量反应:激酶-磷酸酶复合物形成的作用
BMC Syst Biol. 2012 Apr 24;6:26. doi: 10.1186/1752-0509-6-26.
8
S100 proteins modulate protein phosphatase 5 function: a link between CA2+ signal transduction and protein dephosphorylation.S100 蛋白调节蛋白磷酸酶 5 的功能:钙信号转导与蛋白去磷酸化之间的联系。
J Biol Chem. 2012 Apr 20;287(17):13787-98. doi: 10.1074/jbc.M111.329771. Epub 2012 Mar 7.
9
Conformational switching of the molecular chaperone Hsp90 via regulated phosphorylation.通过调控磷酸化实现分子伴侣 Hsp90 的构象转换。
Mol Cell. 2012 Feb 24;45(4):517-28. doi: 10.1016/j.molcel.2011.12.031.
10
Signalling by protein phosphatases and drug development: a systems-centred view.蛋白磷酸酶的信号转导与药物研发:以系统为中心的观点。
FEBS J. 2013 Jan;280(2):751-65. doi: 10.1111/j.1742-4658.2012.08522.x. Epub 2012 Mar 14.